Literature DB >> 16094580

Pain medication as an indicator of interference with lifestyle and oral function during recovery after third molar surgery.

McKenzie Snyder1, Daniel A Shugars, Raymond P White, Ceib Phillips.   

Abstract

Purpose This study was designed to assess the impact of taking pain medications, as a more comprehensive indicator of perceived pain, on the extent of interference with lifestyle and oral function during recovery after third molar surgery. Patients and Methods Recovery data after the removal of 4 third molars were available for patients enrolled in an institutional review board-approved, prospective, multicenter clinical trial. A self-administered health-related quality of life instrument, designed to assess a patients perception of recovery for pain, lifestyle, and oral function, was completed each postsurgery day (PSD) for 14 days. Taking pain medications was a proxy for a patients perceived level of pain, adding a more sensitive behavioral component to the report of pain. Each PSD day, the patients who thought that their pain was sufficient to require taking medications (an opioid, a nonsteroidal anti-inflammatory, or the combination) were compared with patients not taking pain medications. The extent of interference in lifestyle (daily activity, social life, recreation, sleep) and in oral function (eating, chewing, mouth opening) as self-reported on a scale of 1 (no trouble) to 5 (lots of trouble) were compared for those taking and not taking medications using Cochran-Mantel-Haenszel row mean statistics ( P < .05). Results The 445 study patients were mostly female (63%) and white (86%). Median age was 20 years (IQ, 18, 24 years). Median surgery time was 30 minutes (IQ, 20, 40 minutes). Both mandibular third molars were below the occlusal plane in 60%. Almost all patients took pain medication on PSD 1. By PSD 7, 48% of patients were taking pain medication, decreasing to 20% by PSD 11. Patients with pain sufficient to take an analgesic reported a greater extent of interference for all lifestyle and oral function measures. Recovery was significantly delayed for PSD 2 through 14 for patients who took medications ( P < 0.01). Recovery for females taking pain medications was significantly delayed compared with that for males. Conclusions Patients with pain sufficient to prompt taking pain medications were likely to report interference with recovery for lifestyle and oral function. A patients choice to take pain medication appears to be a better indicator of a patients perceived pain and the impact of that pain on recovery than numerical pain scales. This method provides more sensitive behavioral information during the period of recovery after third molar removal.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094580     DOI: 10.1016/j.joms.2005.04.004

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  11 in total

1.  Users' guide to the surgical literature: how to assess an article using surrogate end points.

Authors:  Lucas Gallo; Cagla Eskicioglu; Luis H Braga; Forough Farrokhyar; Achilleas Thoma
Journal:  Can J Surg       Date:  2017-08       Impact factor: 2.089

2.  Cryotherapy and topical minocycline as adjunctive measures to control pain after third molar surgery: an exploratory study.

Authors:  Savannah Gelesko; Leann Long; Jan Faulk; Ceib Phillips; Carolyn Dicus; Raymond P White
Journal:  J Oral Maxillofac Surg       Date:  2011-07-29       Impact factor: 1.895

3.  Recovery after orthognathic surgery: short-term health-related quality of life outcomes.

Authors:  Ceib Phillips; George Blakey; Michael Jaskolka
Journal:  J Oral Maxillofac Surg       Date:  2008-10       Impact factor: 1.895

4.  Patient morbidity and root coverage outcomes after the application of a subepithelial connective tissue graft in combination with a coronally advanced flap or via a tunneling technique: a randomized controlled clinical trial.

Authors:  Luca Gobbato; Jose Nart; Eriberto Bressan; Fabio Mazzocco; Gianluca Paniz; Diego Lops
Journal:  Clin Oral Investig       Date:  2016-01-27       Impact factor: 3.573

5.  Effect of submucosal or oral administration of prednisolone on postoperative sequelae following surgical extraction of impacted mandibular third molar: A randomized controlled study.

Authors:  Adebayo Aremu Ibikunle; Wasiu Lanre Adeyemo; Akinola Ladipo Ladeinde
Journal:  Niger Med J       Date:  2016 Sep-Oct

6.  Efficacy of Preoperative Administration of Paracetamol-Codeine on Pain following Impacted Mandibular Third Molar Surgery: A Randomized, Split-Mouth, Placebo-Controlled, Double-Blind Clinical Trial.

Authors:  Maria Paola Cristalli; Gerardo La Monaca; Chiara De Angelis; Nicola Pranno; Susanna Annibali
Journal:  Pain Res Manag       Date:  2017-02-23       Impact factor: 3.037

Review 7.  New Findings on Local Tramadol Use in Oral Surgery.

Authors:  Petar Đanić; Ivan Salarić; Darko Macan
Journal:  Acta Stomatol Croat       Date:  2017-12

8.  Tramadol versus ketorolac for pain management after third molar surgery.

Authors:  Jugajyoti Pathi; K C Vidya; N C Sangamesh
Journal:  Natl J Maxillofac Surg       Date:  2020-12-16

9.  Pain control following impacted third molar surgery with bupivacaine irrigation of tooth socket: a prospective study.

Authors:  Reza Khorshidi Khiavi; Maghsood Pourallahverdi; Ayda Pourallahverdi; Saadat Ghorani Khiavi; Sina Ghertasi Oskouei; Hadi Mokhtari
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2010-12-21

10.  Oral health-related quality of life following non-surgical (routine) tooth extraction: A pilot study.

Authors:  Wasiu L Adeyemo; Olanrewaju A Taiwo; Olabisi H Oderinu; Moshood F Adeyemi; Akinola L Ladeinde; Mobolanle O Ogunlewe
Journal:  Contemp Clin Dent       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.